Diabetic cardiomyopathy: Target immune cell from mechanism to treatment Article

Lv, Jingyi, Bao, Xiaoyi, Jiao, Xiaolu et al. (2026). Diabetic cardiomyopathy: Target immune cell from mechanism to treatment . INTERNATIONAL IMMUNOPHARMACOLOGY, 186 10.1016/j.intimp.2026.117116

cited authors

  • Lv, Jingyi; Bao, Xiaoyi; Jiao, Xiaolu; Jiang, Yue; Lin, Maoning; Zhang, Wenbin; Wang, Min

authors

publication date

  • October 1, 2026

published in

keywords

  • AMELIORATES CARDIAC FIBROSIS
  • CONGESTIVE-HEART-FAILURE
  • Diabetic cardiomyopathy
  • HIGH GLUCOSE
  • Hyperglycemia
  • INFLAMMATORY RESPONSE
  • INSULIN-RESISTANCE
  • Immune cells
  • Immunology
  • Inflammation
  • Life Sciences & Biomedicine
  • MACROPHAGE POLARIZATION
  • MAST-CELLS
  • MESENCHYMAL STEM-CELLS
  • Pharmacology & Pharmacy
  • REGULATORY T-CELLS
  • Science & Technology
  • TRAINED IMMUNITY
  • Trained immunity

Digital Object Identifier (DOI)

publisher

  • ELSEVIER

volume

  • 186